Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis

To assess the therapeutic response to brolucizumab and aflibercept by deep learning/OCT-based analysis of macular fluid volumes in neovascular age-related macular degeneration. In this post-hoc analysis of two phase III, randomised, multi-centre studies (HAWK/HARRIER), 1078 and 739 treatment-naive e...

Full description

Saved in:

Bibliographic Details
Published in:	Eye (London) Vol. 37; no. 6; pp. 1160 - 1169
Main Authors:	Schmidt-Erfurth, Ursula, Mulyukov, Zufar, Gerendas, Bianca S, Reiter, Gregor S, Lorand, Daniel, Weissgerber, Georges, Bogunović, Hrvoje
Format:	Journal Article
Language:	English
Published:	England Nature Publishing Group 01.04.2023
Subjects:	Acuity Age Angiogenesis Inhibitors - therapeutic use Animals Deep Learning Hawks Humans Intravitreal Injections Macular degeneration Monoclonal antibodies Ranibizumab - therapeutic use Retinal Detachment Subretinal Fluid Tomography, Optical Coherence Vascular Endothelial Growth Factor A Wet Macular Degeneration - drug therapy
ISSN:	0950-222X, 1476-5454, 1476-5454
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!